2026 NPPES data Specialist NPI 1255320511 M.D.
Verify on CMS →

Sreenivas Chintalapani, M.D.

Specialist in Davenport, Iowa.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,608 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 470 beneficiaries · Specialist avg: 1K
Generic prescribing
83%
generic claims · 17% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$140.37
7 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Sreenivas Chintalapani, M.D. filed 1,131 Medicare Part D claims in 2023 as a Specialist in Davenport, Iowa, prescribing 83% generic.

1K
Part D claims, 2023
83%
generic prescribing
$140.37
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Sreenivas Chintalapani, M.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

1,131 Top 23% higher than 77% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). Below this entry. 800–1,000: 40,919 prescribers (3%). Below this entry. 1,000–1,200: 31,827 prescribers (2%). This entry sits in this band. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about Sreenivas Chintalapani, M.D.?

Quality data not reported

NPI registry status

Active

Issued 10/19/2005

NPI 1255320511

Primary specialty

Specialist

High-volume

69,608 US NPIs in this specialty

Medicare Part D claims

1,131 23% vs specialty avg

2023 prescription claims

Specialty avg: 1,474

Specialty distribution in Iowa

How Specialist compares to other specialties among Iowa providers

Iowa providers
Pharmacist - 6.6%Pharmacist6.6%Physical Therapist - 5.5%Physical Therapist5.5%Mental Health Counselor - 5%Mental Health Counselor5%Family Medicine Physician - 4.8%Family Medicine Physician4.8%Chiropractor - 4.2%Chiropractor4.2%Clinical Social Worker - 4.1%Clinical Social Worker4.1%Specialist - 0.3%Specialist0.3%
Largest specialties in Iowa (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Specialist. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Sreenivas Chintalapani, M.D. appears in the CMS NPPES registry as a Specialist provider holding M.D. credentials at 5041 UTICA RIDGE RD, Davenport, IA, 52807, with a listed phone of (563) 359-9696. NPI 1255320511 was issued on 10/19/2005.

Medicare Part D records for calendar year 2023 show 1,131 prescription claims written by this provider, covering 470 Medicare beneficiaries and totaling roughly $299K in drug spend, split 17% brand-name and 83% generic by claim count.

Specialist is a high-volume specialty nationwide, with 69,608 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5041 UTICA RIDGE RD
Davenport, IA 52807

Provider Details

NPI 1255320511
Specialty Specialist
Credentials M.D.
Gender Male
NPI Issued 10/19/2005

Hospital and facility affiliations

Facilities where Sreenivas Chintalapani, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Gastrointestinal Clinic OF Quad Cities PC
Moline, IL

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sreenivas Chintalapani, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$140

Largest payer

Mauna Kea Technologies, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Sreenivas Chintalapani, M.D. - brand share 17.0%
Specialist average

17% brand-name claims vs 83% generic, on 1,131 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,131
Total Claims
$299K
Total Drug Cost
470
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,850
Total Day Supply
46,594
Brand vs Generic
17% brand / 83% generic
Brand Drug Cost
$246K
Generic Drug Cost
$53K
Antibiotic Claims
12

Patient Demographics

Average Patient Age
73.1 years
Avg HCC Risk Score
1.36
Gender Split
55% female / 45% male
Age Distribution
<65: 41, 65-74: 218, 75-84: 184, 85+: 27

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Sreenivas Chintalapani, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Omeprazole
353
Pantoprazole Sodium
87
Azathioprine
44
Mesalamine
44
Linzess
Linaclotide
40
Sulfasalazine
28
Famotidine
26
Humira(Cf) Pen
Adalimumab
18
Ursodiol
18
Esomeprazole Magnesium
17

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Specialist Overview

How Sreenivas Chintalapani, M.D. fits within the Specialist landscape nationally.

69,608
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider

Sreenivas Chintalapani, M.D.'s 1,131 claims are below the specialty average of 1,474.

Nearby Specialist Providers in Iowa

Other clinicians with the same primary specialty enrolled in Iowa, drawn from the same CMS NPPES roster as Chintalapani.

Compare Specialist nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Iowa medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Sreenivas Chintalapani, M.D.'s specialty?
Sreenivas Chintalapani, M.D. specializes in Specialist and practices in Davenport, Iowa. Credentials: M.D..
How much does Sreenivas Chintalapani, M.D. prescribe under Medicare Part D?
In 2023, Sreenivas Chintalapani, M.D. wrote 1,131 Medicare Part D claims totaling $299K in drug costs for 470 beneficiaries.
Where is Sreenivas Chintalapani, M.D. located?
Sreenivas Chintalapani, M.D. is located at 5041 UTICA RIDGE RD, Davenport, IA, 52807. Phone: (563) 359-9696.
What is Sreenivas Chintalapani, M.D.'s NPI number?
Sreenivas Chintalapani, M.D.'s National Provider Identifier (NPI) is 1255320511, issued on 10/19/2005.
Does Sreenivas Chintalapani, M.D. prescribe more brand-name or generic drugs?
Sreenivas Chintalapani, M.D.'s prescribing is 17% brand-name and 83% generic drugs by claim count, with $246K in brand drug costs.
How many Specialist providers are there in the US?
There are 69,608 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does Sreenivas Chintalapani, M.D. prescribe most often?
Based on 2023 Medicare Part D data, Sreenivas Chintalapani, M.D.'s most frequently prescribed drugs include Omeprazole, Pantoprazole Sodium, Azathioprine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sreenivas Chintalapani, M.D. accept Medicare?
Sreenivas Chintalapani, M.D. appears in CMS Medicare data with 1,131 Part D claims and 470 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sreenivas Chintalapani, M.D.'s credentials?
Sreenivas Chintalapani, M.D.'s NPI is 1255320511 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.